CN103041066A - 治疗单纯疱疹病毒性角膜炎的中药组合物及其制备方法 - Google Patents
治疗单纯疱疹病毒性角膜炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN103041066A CN103041066A CN2012105908907A CN201210590890A CN103041066A CN 103041066 A CN103041066 A CN 103041066A CN 2012105908907 A CN2012105908907 A CN 2012105908907A CN 201210590890 A CN201210590890 A CN 201210590890A CN 103041066 A CN103041066 A CN 103041066A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- filtrate
- herba
- weight
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 142
- 239000000203 mixture Substances 0.000 title claims abstract description 69
- 238000000034 method Methods 0.000 title claims description 18
- 206010023332 keratitis Diseases 0.000 title abstract description 7
- 230000003612 virological effect Effects 0.000 title abstract description 4
- 208000009889 Herpes Simplex Diseases 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 claims abstract description 65
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 25
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 24
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 24
- 235000008434 ginseng Nutrition 0.000 claims abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 122
- 239000000706 filtrate Substances 0.000 claims description 120
- 239000000843 powder Substances 0.000 claims description 56
- 210000000582 semen Anatomy 0.000 claims description 49
- 241000628997 Flos Species 0.000 claims description 48
- 238000001914 filtration Methods 0.000 claims description 48
- 238000000605 extraction Methods 0.000 claims description 41
- 238000010438 heat treatment Methods 0.000 claims description 41
- 239000003889 eye drop Substances 0.000 claims description 40
- 238000010992 reflux Methods 0.000 claims description 40
- 238000003756 stirring Methods 0.000 claims description 38
- 239000007788 liquid Substances 0.000 claims description 37
- 238000002360 preparation method Methods 0.000 claims description 37
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 33
- 206010073938 Ophthalmic herpes simplex Diseases 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 239000012153 distilled water Substances 0.000 claims description 30
- 208000005100 Herpetic Keratitis Diseases 0.000 claims description 26
- 239000010231 banlangen Substances 0.000 claims description 25
- 239000008589 Cortex Fraxini Substances 0.000 claims description 24
- 241000208340 Araliaceae Species 0.000 claims description 23
- 239000009636 Huang Qi Substances 0.000 claims description 23
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 23
- 239000002253 acid Substances 0.000 claims description 22
- 238000001802 infusion Methods 0.000 claims description 21
- 238000007598 dipping method Methods 0.000 claims description 20
- 239000006196 drop Substances 0.000 claims description 20
- 238000000926 separation method Methods 0.000 claims description 20
- 238000007873 sieving Methods 0.000 claims description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 19
- 239000008227 sterile water for injection Substances 0.000 claims description 16
- 238000003958 fumigation Methods 0.000 claims description 14
- 239000006071 cream Substances 0.000 claims description 13
- 239000002552 dosage form Substances 0.000 claims description 12
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 11
- 229940049638 carbomer homopolymer type c Drugs 0.000 claims description 11
- 229940043234 carbomer-940 Drugs 0.000 claims description 11
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 11
- 229920000053 polysorbate 80 Polymers 0.000 claims description 11
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 8
- 229930195725 Mannitol Natural products 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 239000000594 mannitol Substances 0.000 claims description 8
- 235000010355 mannitol Nutrition 0.000 claims description 8
- 239000012982 microporous membrane Substances 0.000 claims description 8
- 238000012856 packing Methods 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 7
- 239000011259 mixed solution Substances 0.000 claims description 6
- 238000001879 gelation Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 54
- 230000004438 eyesight Effects 0.000 abstract description 22
- 230000036737 immune function Effects 0.000 abstract description 8
- 210000000987 immune system Anatomy 0.000 abstract description 5
- 238000011084 recovery Methods 0.000 abstract description 5
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 4
- 230000000840 anti-viral effect Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 235000006533 astragalus Nutrition 0.000 abstract 2
- 240000006995 Abutilon theophrasti Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241001113925 Buddleja Species 0.000 abstract 1
- 241000928504 Centipeda minima Species 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 241000300213 Eriocaulon buergerianum Species 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 241000207925 Leonurus Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 241000218231 Moraceae Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000003705 Senecio vulgaris Species 0.000 abstract 1
- 241001530209 Swertia Species 0.000 abstract 1
- 229940105847 calamine Drugs 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 229910052864 hemimorphite Inorganic materials 0.000 abstract 1
- 238000004904 shortening Methods 0.000 abstract 1
- 235000014692 zinc oxide Nutrition 0.000 abstract 1
- 239000011787 zinc oxide Substances 0.000 abstract 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 59
- 210000001508 eye Anatomy 0.000 description 33
- 210000004087 cornea Anatomy 0.000 description 27
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 24
- 201000010099 disease Diseases 0.000 description 23
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 230000001717 pathogenic effect Effects 0.000 description 21
- 241000475481 Nebula Species 0.000 description 19
- 206010030113 Oedema Diseases 0.000 description 18
- 208000002193 Pain Diseases 0.000 description 16
- 210000005252 bulbus oculi Anatomy 0.000 description 16
- 230000036407 pain Effects 0.000 description 16
- 210000003734 kidney Anatomy 0.000 description 14
- 244000052769 pathogen Species 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 12
- 239000000499 gel Substances 0.000 description 12
- 231100000614 poison Toxicity 0.000 description 12
- 208000037920 primary disease Diseases 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 11
- 230000008961 swelling Effects 0.000 description 11
- 206010015150 Erythema Diseases 0.000 description 10
- 230000035617 depilation Effects 0.000 description 10
- 208000001848 dysentery Diseases 0.000 description 10
- 231100000321 erythema Toxicity 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 9
- 241000201295 Euphrasia Species 0.000 description 9
- 239000003440 toxic substance Substances 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 206010034960 Photophobia Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 206010037660 Pyrexia Diseases 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 210000000232 gallbladder Anatomy 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 206010010726 Conjunctival oedema Diseases 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 208000031971 Yin Deficiency Diseases 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 239000007850 fluorescent dye Substances 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 206010023365 keratopathy Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 241000700199 Cavia porcellus Species 0.000 description 5
- 208000000993 Dendritic Keratitis Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 5
- 229940020947 fluorescein sodium Drugs 0.000 description 5
- 201000010884 herpes simplex virus keratitis Diseases 0.000 description 5
- 206010022000 influenza Diseases 0.000 description 5
- 231100000915 pathological change Toxicity 0.000 description 5
- 230000036285 pathological change Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 102000015612 Complement 3b Receptors Human genes 0.000 description 4
- 108010024114 Complement 3b Receptors Proteins 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 241000700584 Simplexvirus Species 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 208000009205 Tinnitus Diseases 0.000 description 4
- 206010047513 Vision blurred Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 231100000886 tinnitus Toxicity 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 241000555268 Dendroides Species 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010037508 Punctate keratitis Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000012886 Vertigo Diseases 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 3
- 229960002327 chloral hydrate Drugs 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229940012356 eye drops Drugs 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 201000003827 punctate epithelial keratoconjunctivitis Diseases 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 231100000889 vertigo Toxicity 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 2
- 208000019838 Blood disease Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 206010052369 Encephalitis lethargica Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 241000237955 Nassarius Species 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000002567 autonomic effect Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 210000003746 feather Anatomy 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 208000014951 hematologic disease Diseases 0.000 description 2
- 208000018706 hematopoietic system disease Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000000622 irritating effect Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 201000002498 viral encephalitis Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 230000004382 visual function Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010052129 Ciliary hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000006069 Corneal Opacity Diseases 0.000 description 1
- 206010061788 Corneal infection Diseases 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010049119 Emotional distress Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010051814 Eschar Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010015943 Eye inflammation Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023335 Keratitis interstitial Diseases 0.000 description 1
- 208000032420 Latent Infection Diseases 0.000 description 1
- 241001215120 Leptospirales Species 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 208000006550 Mydriasis Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 240000007509 Phytolacca dioica Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 101100503586 Rattus norvegicus Furin gene Proteins 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 208000008630 Sialorrhea Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 208000009257 Visceral Prolapse Diseases 0.000 description 1
- 206010063840 Visceroptosis Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229940097572 chloromycetin Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 235000021402 commercial pellet diet Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 231100000269 corneal opacity Toxicity 0.000 description 1
- 210000003683 corneal stroma Anatomy 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000037771 disease arising from reactivation of latent virus Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000005081 epithelial layer Anatomy 0.000 description 1
- 210000003560 epithelium corneal Anatomy 0.000 description 1
- 231100000333 eschar Toxicity 0.000 description 1
- 230000017188 evasion or tolerance of host immune response Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000012757 fluorescence staining Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960002963 ganciclovir Drugs 0.000 description 1
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 201000006904 interstitial keratitis Diseases 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 201000000909 keratomalacia Diseases 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000001749 optic atrophy Diseases 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012428 routine sampling Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000000162 simple eye Anatomy 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001745 uvea Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
刺激反应 | 分值 |
红斑 | |
无红斑 | 0 |
轻度红斑(勉强可见) | 1 |
中度红斑(明显可见) | 2 |
重度红斑 | 3 |
紫红色红斑到轻度焦痂形成 | 4 |
水肿 | |
无水肿 | 0 |
轻度水肿(勉强可见) | 1 |
中度水肿(明显隆起) | 2 |
重度水肿(皮肤隆起1mm,轮廓清楚) | 3 |
严重水肿(皮肤隆起1mm以上并有扩大) | 4 |
分值 | 评价 |
0~0.49 | 无刺激性 |
0.5~2.99 | 轻度刺激性 |
3.0~5.99 | 中度刺激性 |
6.0~8.00 | 重度刺激性 |
组别 | 造模前 | 7d | 14d | 21d |
空白组 | 0±0 | 0±0 | 0±0 | 0±0 |
模型组 | 0±0 | 2.46±0.96 | 2.72±1.07 | 2.92±0.87 |
治疗组 | 0±0 | 1.24±0.59 | 0.59±0.29 | 0.13±0.09 |
组别 | 红细胞C3b受体花环率(%) |
空白组 | 20.13±1.59 |
模型组 | 13.68±1.02 |
治疗组 | 21.73±1.39 |
组别 | 眼数(只) | 痊愈 | 好转 | 无效 | 总有效率(%) |
治疗组 | 120 | 83 | 33 | 4 | 96.67 |
对照组 | 103 | 46 | 43 | 14 | 86.40 |
组别 | 眼数(只) | 疗效开始时间(天) | 疗程(天) |
治疗组 | 120 | 3.27±1.01 | 16.29±2.18 |
对照组 | 103 | 5.73±0.83 | 22.09±3.05 |
组别 | 随机跟踪的痊愈病例 | 复发病例 |
治疗组 | 52 | 3 |
对照组 | 37 | 7 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210590890.7A CN103041066B (zh) | 2012-12-29 | 2012-12-29 | 治疗单纯疱疹病毒性角膜炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210590890.7A CN103041066B (zh) | 2012-12-29 | 2012-12-29 | 治疗单纯疱疹病毒性角膜炎的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103041066A true CN103041066A (zh) | 2013-04-17 |
CN103041066B CN103041066B (zh) | 2014-08-20 |
Family
ID=48054077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210590890.7A Expired - Fee Related CN103041066B (zh) | 2012-12-29 | 2012-12-29 | 治疗单纯疱疹病毒性角膜炎的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103041066B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015010205A1 (en) * | 2013-07-22 | 2015-01-29 | Université Du Québec À Chicoutimi | Use of plant extracts against herpes simplex virus |
CN105267271A (zh) * | 2015-10-28 | 2016-01-27 | 葛善文 | 一种治疗病毒性角膜炎的中药组合物及其制备方法和用途 |
CN113350369A (zh) * | 2021-06-26 | 2021-09-07 | 扬州大学 | 车前草多糖在制备抗猪伪狂犬病病毒感染制剂中的应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101081249A (zh) * | 2006-05-29 | 2007-12-05 | 孙耀祖 | 一种可明目的中药 |
CN101085174A (zh) * | 2007-06-15 | 2007-12-12 | 张铁牛 | 一种补肾明目保健中药口服液 |
CN101152326A (zh) * | 2007-09-20 | 2008-04-02 | 吴月 | 治疗复发性疱疹病毒角膜炎的中药 |
CN101164579A (zh) * | 2007-09-20 | 2008-04-23 | 吴月 | 治疗角膜炎的中药 |
CN101450155A (zh) * | 2007-12-03 | 2009-06-10 | 陈海生 | 一种治疗眼病的中草药 |
CN102552777A (zh) * | 2012-02-15 | 2012-07-11 | 刘静 | 治疗单纯疱疹病毒性角膜炎的药物及其制备方法 |
-
2012
- 2012-12-29 CN CN201210590890.7A patent/CN103041066B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101081249A (zh) * | 2006-05-29 | 2007-12-05 | 孙耀祖 | 一种可明目的中药 |
CN101085174A (zh) * | 2007-06-15 | 2007-12-12 | 张铁牛 | 一种补肾明目保健中药口服液 |
CN101152326A (zh) * | 2007-09-20 | 2008-04-02 | 吴月 | 治疗复发性疱疹病毒角膜炎的中药 |
CN101164579A (zh) * | 2007-09-20 | 2008-04-23 | 吴月 | 治疗角膜炎的中药 |
CN101450155A (zh) * | 2007-12-03 | 2009-06-10 | 陈海生 | 一种治疗眼病的中草药 |
CN102552777A (zh) * | 2012-02-15 | 2012-07-11 | 刘静 | 治疗单纯疱疹病毒性角膜炎的药物及其制备方法 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015010205A1 (en) * | 2013-07-22 | 2015-01-29 | Université Du Québec À Chicoutimi | Use of plant extracts against herpes simplex virus |
US10716821B2 (en) | 2013-07-22 | 2020-07-21 | Université Du Québec A Chicoutimi | Use of plant extracts against herpes simplex virus |
CN105267271A (zh) * | 2015-10-28 | 2016-01-27 | 葛善文 | 一种治疗病毒性角膜炎的中药组合物及其制备方法和用途 |
CN113350369A (zh) * | 2021-06-26 | 2021-09-07 | 扬州大学 | 车前草多糖在制备抗猪伪狂犬病病毒感染制剂中的应用 |
CN113350369B (zh) * | 2021-06-26 | 2022-03-29 | 扬州大学 | 车前草多糖在制备抗猪伪狂犬病病毒感染制剂中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103041066B (zh) | 2014-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101455738B (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
CN102205026B (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN102178800B (zh) | 一种治疗类风湿性关节炎的中药组合物及其制备方法 | |
CN108853404A (zh) | 一种治疗皮肤及黏膜疾病的中药复方制剂及其制备方法 | |
CN102178880A (zh) | 一种治疗寒冷敏感型冻伤的中药制备方法 | |
CN104274788A (zh) | 一种治疗妇女肝火湿热型带下的中药组合物及其制备方法 | |
CN103083546B (zh) | 障眼复明浓缩丸的加工方法 | |
CN103041066B (zh) | 治疗单纯疱疹病毒性角膜炎的中药组合物及其制备方法 | |
CN103721000A (zh) | 用于治疗流行性角结膜炎的药物制剂 | |
CN103720841B (zh) | 一种治疗慢性化脓性中耳炎的中药制剂及其制备方法 | |
CN103007014A (zh) | 一种用于治疗干眼症的中药组合物及制备方法 | |
CN106806758A (zh) | 一种治疗痤疮的中药制剂 | |
CN104306637A (zh) | 一种治疗妇女脾虚湿盛型带下的中药组合物及其制备方法 | |
CN107929670A (zh) | 一种治疗视力模糊的药物眼罩及其制备方法 | |
CN107213360A (zh) | 一种治疗重型肌无力的中药组合物 | |
CN103028046B (zh) | 用于治疗萎缩性鼻炎的中药组合物及其制备方法 | |
CN105194427A (zh) | 一种治疗干眼症的中药组合物及其制备方法 | |
CN104306832A (zh) | 一种治疗邪毒犯心型病毒性心肌炎的中药制剂及其制备方法 | |
CN103920042A (zh) | 用于治疗热陷营血型病毒性脑膜炎的药物及其制备方法 | |
CN103495119B (zh) | 用于治疗气滞血瘀型慢性前列腺炎的药物 | |
CN102755549A (zh) | 一种治疗白内障的药物及其制备方法 | |
CN102205057B (zh) | 一种治疗结膜充血型小儿流行性感冒的中药的制备方法 | |
CN105288372A (zh) | 一种治疗原发性痛经伴痤疮的药物制剂 | |
CN105395718A (zh) | 一种治疗病毒性角膜炎的外用中药组合物 | |
CN104784558A (zh) | 一种治疗复发性口腔溃疡的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yu Haifang Inventor after: Sun Haiping Inventor after: Sun Yanli Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: YU HAIFANG SUN HAIPING SUN YANLI |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171020 Address after: Lang Jun Center No. 28 road 401120 Chongqing city Yubei District Huanglong longta Street Building 3 2-1 Patentee after: Chongqing AOPO Ruisen Technology Co. Ltd. Address before: 266071 Shandong province Qingdao City Road No. 19 east red room unit 7 Patentee before: Qingdao Hengbo Instrument Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180327 Address after: 401120 Chongqing Yubei District Hui Xing Street Xingke Road No. 293 with mountain name 7 9 Patentee after: CHONGQING XUANNU BIOTECHNOLOGY CO., LTD. Address before: Lang Jun Center No. 28 road 401120 Chongqing city Yubei District Huanglong longta Street Building 3 2-1 Patentee before: Chongqing AOPO Ruisen Technology Co. Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140820 Termination date: 20181229 |